Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism
Sponsor: Children's Hospital Medical Center, Cincinnati
This PHASE3 trial investigates Adrenoleukodystrophy and Cholestasis and is currently completed. Children's Hospital Medical Center, Cincinnati leads this study, which shows 11 recorded versions since 1992 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Nov 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2021 — Nov 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE3
▶ Show 6 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Sep 2020 — Oct 2020 [monthly]
Completed PHASE3
-
Aug 2020 — Sep 2020 [monthly]
Completed PHASE3
-
Jun 2018 — Aug 2020 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jan 1992
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
- Mirum Pharmaceuticals, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .